{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:52:03Z","timestamp":1791352323965,"version":"4.3.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.euroneuro.2005.11.006","type":"journal-article","created":{"date-parts":[[2006,1,10]],"date-time":"2006-01-10T12:08:03Z","timestamp":1136894883000},"page":"413-416","source":"Crossref","is-referenced-by-count":40,"title":["Increased use of mental health services related to Isotretinoin treatment: A 5-year analysis"],"prefix":"10.1016","volume":"16","author":[{"given":"Tal","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonit","family":"Wohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim Y.","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gadi","family":"Lubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehezkel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.euroneuro.2005.11.006_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004850-200501000-00008","article-title":"Affective psychosis following Accutane (Isotretinoin) treatment","volume":"20","author":"Barak","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib2","first-page":"64","article-title":"Does Isotretinoin cause depression and suicide?","volume":"37","author":"Bremner","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1176\/appi.ajp.162.5.983","article-title":"Functional brain imaging alterations in acne patients treated with Isotretinoin","volume":"162","author":"Bremner","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.11.006_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2133.1998.02511.x","article-title":"Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis","volume":"139","author":"Gupta","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/sder.2001.28209","article-title":"Safety issues in Isotretinoin therapy","volume":"20","author":"Hanson","year":"2001","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1067\/S0190-9622(03)02087-5","article-title":"Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis","volume":"49","author":"Hersom","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00128071-200304070-00005","article-title":"Isotretinoin use and subsequent depression and suicide: presenting the evidence","volume":"4","author":"Hull","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.adolescence.2004.07.004","article-title":"Evolved mechanisms in adolescent anxiety and depression symptoms: the role of the attachment and social rank systems","volume":"28","author":"Irons","year":"2005","journal-title":"J. Adolesc."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib9","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1067\/mjd.2001.118233","article-title":"Suicide, depression, and Isotretinoin: is there a causal link?","volume":"45","author":"Jacobs","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1440-1614.2003.01111.x","article-title":"The association between depression and Isotretinoin use in acne","volume":"37","author":"Ng","year":"2003","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.11.006_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00045391-200303000-00012","article-title":"Overview of existing research and information linking Isotretinoin (Accutane) depression, psychosis, and suicide","volume":"10","author":"O'Donnell","year":"2003","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib13","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1176\/appi.ajp.159.12.2027","article-title":"A population-based cohort study of premorbid intellectual, language, and behavioral functioning in Patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder","volume":"159","author":"Reichenberg","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.11.006_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1440-0960.2004.00078.x","article-title":"Psychiatric morbidity in psoriasis: a review","volume":"45","author":"Russo","year":"2004","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1521\/suli.35.1.14.59266","article-title":"The mediating roles of anxiety depression, and hopelessness on adolescent suicidal behaviors","volume":"35","author":"Thompson","year":"2005","journal-title":"Suicide Life-Threat. Behav."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib16","first-page":"4","article-title":"Medical quality assessment program in drafting centers","volume":"2","author":"Wohl","year":"2005","journal-title":"J. Isr. Mil. Med."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib17","first-page":"66","article-title":"Accutane (Isotretinoin) and psychiatric adverse effects","volume":"168","author":"Wooltorton","year":"2003","journal-title":"JAMC"},{"key":"10.1016\/j.euroneuro.2005.11.006_bib18","first-page":"1102","article-title":"Methodological limitations of the study \u201cIsotretinoin use and the risk of depression, psychotic symptoms, suicide and attempted suicide\u201d","volume":"137","author":"Wysowski","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/archderm.141.5.640","article-title":"Relationship between headache and depression in users of Isotretinoin","volume":"141","author":"Wysowski","year":"2005","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.120529","article-title":"Use of Isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000","volume":"46","author":"Wysowski","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2005.11.006_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1460-9568.1999.00444.x","article-title":"Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid","volume":"11","author":"Zetterstrom","year":"1999","journal-title":"Eur. J. Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05001859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05001859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T06:20:33Z","timestamp":1547878833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X05001859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0924977X05001859"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2005.11.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}